The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice

Circulation Research
Chien-Sung ChiangChien-Chang Chen

Abstract

Voltage-gated T-type Ca(2+) channels (T-channels) are normally expressed during embryonic development in ventricular myocytes but are undetectable in adult ventricular myocytes. Interestingly, T-channels are reexpressed in hypertrophied or failing hearts. It is unclear whether T-channels play a role in the pathogenesis of cardiomyopathy and what the mechanism might be. Here we show that the alpha(1H) voltage-gated T-type Ca(2+) channel (Ca(v)3.2) is involved in the pathogenesis of cardiac hypertrophy via the activation of calcineurin/nuclear factor of activated T cells (NFAT) pathway. Specifically, pressure overload-induced hypertrophy was severely suppressed in mice deficient for Ca(v)3.2 (Ca(v)3.2(-/-)) but not in mice deficient for Ca(v)3.1 (Ca(v)3.1(-/-)). Angiotensin II-induced cardiac hypertrophy was also suppressed in Ca(v)3.2(-/-) mice. Consistent with these findings, cultured neonatal myocytes isolated from Ca(v)3.2(-/-) mice fail to respond hypertrophic stimulation by treatment with angiotensin II. Together, these results demonstrate the importance of Ca(v)3.2 in the development of cardiac hypertrophy both in vitro and in vivo. To test whether Ca(v)3.2 mediates the hypertrophic response through the calcineurin/NFAT pa...Continue Reading

References

Jun 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·X P Xu, P M Best
Nov 4, 1998·Journal of Molecular and Cellular Cardiology·R Mukherjee, F G Spinale
Sep 2, 1999·Journal of Molecular and Cellular Cardiology·M L MartínezC Delgado
Feb 13, 2001·Journal of Molecular and Cellular Cardiology·A YataniJ D Molkentin
Apr 2, 2002·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Yunzeng ZouIssei Komuro
Jan 14, 2003·Annual Review of Physiology·N Frey, E N Olson
Nov 15, 2003·Circulation Research·Laurent FerronJean-François Renaud
Nov 25, 2003·Science·Chien-Chang ChenKevin P Campbell
Dec 6, 2003·Circulation Research·Benjamin J WilkinsJeffery D Molkentin
Feb 28, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Noriko NiwaItsuo Kodama
Feb 16, 2005·Annual Review of Physiology·Xander H T WehrensAndrew R Marks
Aug 30, 2005·Annual Review of Genomics and Human Genetics·Ferhaan AhmadChristine E Seidman
Oct 1, 2005·Circulation Journal : Official Journal of the Japanese Circulation Society·Einosuke MizutaIchiro Hisatome
Jul 29, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Hiroyuki NakayamaJeffery D Molkentin
Oct 24, 2006·Trends in Cardiovascular Medicine·Mansoureh EghbaliEnrico Stefani
Oct 28, 2006·Proceedings of the National Academy of Sciences of the United States of America·Kumar PandyaOliver Smithies
Nov 4, 2006·The EMBO Journal·Naoya OnoharaHitoshi Kurose
Nov 14, 2006·The Journal of Clinical Investigation·Koichiro KuwaharaEric N Olson
Dec 19, 2006·Journal of Molecular and Cellular Cardiology·Takayoshi OhbaHiroshi Ito

❮ Previous
Next ❯

Citations

Nov 19, 2010·The Journal of Biological Chemistry·Yogananda S MarkandeyaRavi C Balijepalli
Feb 19, 2013·Cardiovascular Research·Robin M Shaw, Henry M Colecraft
Aug 31, 2011·Cold Spring Harbor Perspectives in Biology·Claire J FearnleyMartin D Bootman
Dec 15, 2010·American Journal of Physiology. Cell Physiology·Florentina Pluteanu, Leanne L Cribbs
Aug 12, 2009·American Journal of Physiology. Heart and Circulatory Physiology·Florentina Pluteanu, Leanne L Cribbs
Nov 19, 2009·The Journal of Clinical Investigation·Hiroyuki NakayamaJeffery D Molkentin
Mar 2, 2010·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Motohiro NishidaHitoshi Kurose
Nov 5, 2010·Circulation Journal : Official Journal of the Japanese Circulation Society·Makoto TakanoKoichiro Kuwahara
Mar 4, 2010·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Mariko Omatsu-KanbeHiroshi Matsuura
Feb 1, 2014·Pflügers Archiv : European journal of physiology·Ivana Y-T KuoCaryl E Hill
Jun 18, 2014·Cardiovascular Research·David L BeaversXander H T Wehrens
Apr 30, 2014·Proceedings of the National Academy of Sciences of the United States of America·Shin-Shiou LinChien-Chang Chen
Dec 22, 2010·The Journal of Physiology·Ivana Y-T KuoCaryl E Hill
Feb 11, 2015·Pharmacology & Therapeutics·Koichiro Kuwahara, Takeshi Kimura
Jul 3, 2013·Trends in Cardiovascular Medicine·Yanggan WangJoseph A Hill
Jul 12, 2011·Trends in Cardiovascular Medicine·Hui-Bin LiuDe-Li Dong
May 8, 2015·The Journal of Veterinary Medical Science·Jumpei YasudaHideyuki Yamawaki
Sep 5, 2009·Journal of Molecular and Cellular Cardiology·Kyoichi Ono, Toshihiko Iijima
Sep 4, 2015·The Journal of Physiology·P González-RodríguezA Castellano
Feb 3, 2015·The Journal of Physiology·William E LouchPasi Tavi
Mar 30, 2016·Pflügers Archiv : European journal of physiology·Keisuke ImotoHideyuki Yamawaki
Oct 5, 2016·Expert Opinion on Investigational Drugs·J Tamargo, Luis Miguel Ruilope
Jan 6, 2017·Channels·Lars Jørn JensenCharlotte Mehlin Sørensen
May 10, 2018·The Journal of Experimental Biology·Jaakko HaverinenMatti Vornanen
Dec 5, 2017·Biological & Pharmaceutical Bulletin·Muneyoshi OkadaHideyuki Yamawaki
Dec 3, 2015·Circulation·Wenjun ZhangWeinian Shou
Jun 13, 2015·Arteriosclerosis, Thrombosis, and Vascular Biology·Osama F HarrazDonald G Welsh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.